|
楼主 |
发表于 2008-12-10 09:49:59
|
显示全部楼层
69-9-第九节 预 后
一、GCA复发以及治疗失败的定义
* @! i0 ]6 F$ Y' L4 e9 h+ n4 N" H' r H$ Z
GCA复发:GCA复发是指ESR由正常升至)40 mm/h,加上以下GCA的特点中的至少一项,这些表现有GCA引起而非其他疾病所致。这些表现为:①发热,T) 38℃至少一周;②出现PMR;③头痛、头皮痛或触痛;④失明;⑤下领或口周疼痛;⑥肢端间歇运动障碍;⑦与血管炎一致的动脉造影异常;⑧脑缺血或脑梗死;⑨其他证实为GCA特点的表现。
: Y' F3 z8 _) H6 W* o. Z7 ]
) Q' _! [# v4 d, o( Z GCA治疗失败:出现2次不同的复发,或使用泼尼松治疗期间出现复发,且较上一有效剂量加大10mg治疗仍不能改善。
! s( G# H# r9 h* m9 L5 [* A7 e+ U: q. F6 O6 t- G0 A
二、预后
# s. I5 w5 `1 ?( R, i# V5 H& p( x# u0 F& d4 o, H/ r$ c
PMR一般为2年期的自限性疾病,较少发展为GCA。GCA的视力受损通常是不可逆,平均需治疗 2年,部分患者需治疗5年或更多。早期报道GCA合并PMR的老年患者病死率为1% -12%,近年来由于早期诊断和治疗的改善,其病死率和同年龄组常人无差异。
3 F) }4 I4 }' C ( 曾小峰 艾脉心 )
3 Q5 ]2 z0 G. N* U1 \, p 参考文献:! D* d) k+ E1 q
$ H+ R6 w. g" Q5 D! |; U7 S
Airo P, Antonioli CM, Vianelli M, et al. Anti-tumournecrosis factor treatment with infliximab in a case of giant cell at-teritis resistant to steroid and immunosuppressive drugs. Rheuma-tology, 2002. 41:347一349 7 M2 x i/ q4 J, G- z3 g( {
; ]6 n# i& w5 b/ r" A$ j
Alpers CE, Davis CL, Barr D. Identification of platelet-de-rived growth factor A and B chains in human renal vascular rejec-tion. Am J Pathol,1996. 148:439一451 ' f. c% w. o) w6 g) d1 `/ o
( s4 I8 ?- E# B Bignon JD, Ferec C, Barrier J. HLA class II genes polymor-phism in DR4 giant cell arteritis patients. Tissue Antigens, 1988.32:254一258 5 U; j4 B$ M0 y# A/ S
F4 y9 p) h$ B, M+ n \
Boyev LR, Miller NR, Green WR. Efficacy of unilateralversus bilateral temporal artery biopsies for the diagnosis of giant cellarteritis [see comments].Am J Ophthalmol,1999.128:211一215
( Y3 S8 h% U ~3 V) u! e8 Q8 G# _8 C6 S d
Brack A, Martinez-Taboada V, Stanson A. Disease patternin cranial and large-vessel giant cell arteritis仁see comments ].Arthritis Rheum, 1999. 42:311一317 8 n8 G9 ]* C8 e
! \4 n! p9 f$ M Cantini F, Salvararni C Olivieri 1, et al. Shoulder ultrasono-graphy in the diagnosis of polymyalgia rheumatica: a case-controlstudy. J Rheumato1,2001.28:1049一1055
/ z2 V0 C; k- U- q' ~" {) m4 f5 @: v; e: g( _3 r$ C8 C
Caporali R, Montecucco C, Epis O, et al. Presenting fea-tures of polymyalgia rheumatica (PMR) and rheumatoid arthritiswith PMR-like onset: a prospective study. Ann Rheum Dis,2001.60:1021一1024 6 G$ M F; E1 d4 z
! [3 ~5 _/ X3 q/ i# w7 n Cid MC, Cebrian M, Font C. Cell adhesion molecules in thedevelopment of inflammatory infiltrates in giant cell arteritis: in-flammation- induced angiogenesis as the preferential site of leukocyte-endothelial cell interactions. Arthritis Rheum, 2000.43:184一194 ' y8 b7 I/ a- J9 B% N. b- p; w
; n- ]. ~8 A* L5 F3 l/ Y! j) ^' Y3 `9 L
Cohen MD, Ginsburg WW. Polymyalgia rheumatica.Rheum Dis Clin North Am, 1990. 16:325一339
. g- X% v! C7 E7 c9 k h/ x* n" }* |) P$ c: N/ z
Dababneh A, Gonzalez-Gay MA, Garcia-Porrua C. Giant cellarteritis and polymyalgia rheumatica can be differentiated by dis-tinct patterns of HLA class II association. J Rheumato1,1998. 25:2140一2145 1 c7 z6 b6 f* G0 z- u7 `
: o) p8 [: E5 {
Ghanchi FD, Dutton GN. Current concepts in giant cell(temporal) arteritis. Surv Ophthalmol,1997.42:99一123 7 w2 \' f1 b- D8 [* j4 [1 U! v
0 `* f5 k% L* c
Gran JT, Myklebust G, Wilsgaard T, et al. Survival inpolymyalgia rheumatica and temporal arteritis: a study of 398 cas-es and matched population controls. Rheumatology (Oxford),2001.40:1238一1242 " N, _* u7 @( ~& Q8 {/ G% n
8 i: v& k% d4 w* y7 S Haworth S, Ridgeway J, Stewart I. Polymyalgia rheumaticais associated with both HLA-DRBI * 0401 and DRBI * 0404. BrJ Rheumatol,1996. 35 :632一635
9 R. g- v5 X0 l% g, c3 Z% V- F4 X, Y" ~. L2 E, V
Helweg-Larsen J, Tarp B, Obel N, et al. No evidence ofparvovirus B19, Chlamydia pneumoniae or human herpes virus in-fection in temporal artery biopsies in patients with giant cell at eritis. Rheumatology,2002.41:445一449
, n; m& w( ?: z1 T( P: `3 @' K4 I/ J2 B3 A
Hoffman GS, Cid MC, Hellmann DB, et al. A multicenter,randomized, double-blind, placebo-controlled trial of adjuvantmethotrexate treatment for giant cell arteritis. Arthritis Rheum,2002.46:9一18
! s+ M) u5 U8 |$ j0 J! w9 c" I! [/ c% F# x8 _6 [" Q
Hunder GG, Bloch DA, Michel BA, et al. The AmericanCollege of Rheumatology 1990 criteria for the classification of gi-ant cell arteritis. Arthritis Rheum, 1990. 33:1122一1128 8 a; A* m X* d6 Q0 L
1 _0 w) j' H8 N
Jover JA, Hernandez-Garcia C, Morado IC. Combined treat-ment of giant-cell 2001
* x, v. W7 t j% X' H3 L l, u& |* s9 w1 e
Kaiser M, Weyand CM, Bjornsson J. Platelet-derivedgrowth factor, intimal hyperplasia, and ischemic complications ingiant cell arteritis. Arthritis Rheum, 1998.41:623一633
! E1 g* B, |( P) b
$ p1 ^4 T! Z& l, X) [. R McGonagle D, Pease C, Marzo-Ortega H, et al. Compari-son of extracapsular changes by magnetic resonance imaging in pa-tients with rheumatoid arthritis and polymyalgia rheumatica. JRheumatol, 2001.28:1937一1941
; x5 Q5 z# B$ n0 q% ?6 r$ I1 S f6 Z
Meliconi R, Pulsatelli L, Uguccioni M. Leukocyte infiltra-tion in synovial tissue from the shoulder of patients withpolymyalgia rheumatica. Quantitative analysis and influence ofcorticosteroid treatment. Arthritis Rheum, 1996. 39:1199一1207
; a8 u \3 C4 [9 H8 t$ l+ O6 D, o' W6 X" R8 B
Narvaez J, Nolla-Sole JM, Clavaguera MT. Longterm thera-py in polymyalgia rheumatica: effect of coexistent temporal arteri-tis. J Rheumato1,1999.26:1945一1952 ; |- g- c9 G- \$ f3 v/ j9 \5 B: u+ N
/ @6 s6 B( Y, u: D
Narvaez J,Nolla-Sole JM, Narvaez JA, et al. Musculoskele-tat manifestations in polymyalgia rheumatica and temporal arteri-tis. Ann Rheum Dis,2001.60:1060一1063 6 g$ u [- ?9 S% d t$ X+ o6 @9 v
" L3 E7 M3 d1 N8 l
Nesher G, Shemesh D, Mates M, et al. The predictive valueof the halo sign in color Doppler ultrasonography of the temporalarteries for diagnosing giant cell arteritis. J Rheumato1,2002.29:1224一1226
. A: P1 w [# [. h0 [1 e Ray-Chaudhuri N, Kine DA, Tijani SO, et al. Effect of priorsteroid treatment on temporal artery biopsy findings in giant cellarteritis. Br J Ophthalmol,2002. 86:530一532
3 M( Q: j/ w" Y" v. {2 O
: j) W/ k q2 ?2 m: I, Q Salvarani C, Cantini F, Olivieri 1. Proximal bursitis in activepolymyalgia rheumatica. Ann Intern Med,1997. 127:27一31
( ? R1 j2 l; D: a3 x5 b1 n
# }$ K4 q; G" k( M) s! C* g# v Schmidt WA, Kraft HE, Vorpahl K. Color duplex ultra-sonography in the diagnosis of temporal arteritis [see comments].N Eng1J Med,1997.337:1336一1342
7 a( H L$ F- @6 ?6 x6 ?0 M
# ?4 c! {" w. o- D) B3 }$ F, e Weyand CM, Goronzy JJ. Arterial wall injury in giant cellarteritis. Arthritis Rheum, 1999. 42:844一853
- V' Q- @2 h7 g8 y Weyand CM, Hicok KC Hunder y. Tissue cytokine pat-terns in patients with polymyalgia rheumatica and giant cell arteri-tis [see comments],Ann Intern Med,1994.121:484一491
6 g$ u: Z5 a5 ?8 |7 Y, G
8 d; I2 Z3 f# I, @( W9 x) g6 m Weyand CM, Kaiser M, Yang Hongyu, et al. Therapeuticeffects of acetylsalicylic acid in giant cell arteritis. ArthritisRheum, 2002. 46:457一466 |
|